DAS28 Group | <2.6 | 2.6 – 3.2 | 3.2 – 5.1 | >5.1 |
---|---|---|---|---|
1996-97 Cohort | ||||
Number of patients, (%) | 15 (8 %) | 8 (4 %) | 72 (38 %) | 94 (50 %) |
Tender joint count, mean (SD) | 0.7 (1.4) | 0.8 (1.4) | 4.9 (4.8) | 16.4 (8.5) |
Swollen joint count, mean (SD) | 0.3 (0.9) | 4.0 (3.6) | 4.5 (3.3) | 10.5 (5.1) |
Patient global, mean (SD) | 14 (7) | 26 (16) | 42 (20) | 64 (21) |
ESR, mean (SD) | 12 (7) | 15 (8) | 30 (27) | 44 (25) |
HAQ, mean (SD) | 0.3 (0.4) | 0.8 (0.8) | 1.0 (0.8) | 1.7 (0.8) |
2001-03 Cohort | ||||
Number of patients, (%) | 29 (9 %) | 32 (10 %) | 115 (37 %) | 135 (43 %) |
Tender joint count, mean (SD) | 0.4 (0.7) | 1.3 (1.6) | 4.6 (4.2) | 12.9 (7.1) |
Swollen joint count, mean (SD) | 0.8 (1.4) | 2.3 (2.6) | 3.5 (2.8) | 7.5 (4.0) |
Patient global, mean (SD) | 15 (19) | 28 (22) | 42 (22) | 70 (22) |
ESR, mean (SD) | 9 (7) | 20 (19) | 26 (21) | 48 (28) |
HAQ, mean (SD) | 0.7 (0.7) | 1.0 (0.7) | 1.4 (0.7) | 1.9 (0.6) |
2013-14 Cohort | ||||
Number of patients, (%) | 148 (28 %) | 67 (13 %) | 212 (41 %) | 93 (18 %) |
Tender joint count, mean (SD) | 0.7 (1.6) | 1.6 (2.4) | 4.7 (4.7) | 15.2 (7.9) |
Swollen joint count, mean (SD) | 0.2 (0.7) | 1.0 (1.6) | 1.9 (2.3) | 5.3 (3.6) |
Patient global, mean (SD) | 24 (17) | 24 (17) | 50 (21) | 73 (16) |
ESR, mean (SD) | 9 (7) | 22 (17) | 26 (18) | 34 (23) |
HAQ, mean (SD) | 0.9 (0.8) | 1.2 (0.8) | 1.4 (0.8) | 1.9 (0.6) |